Differences in thrombotic risk factors in black and white women with adverse pregnancy outcome

Claire S Philipp, Ambarina S Faiz, Michele G Beckman, Althea Grant, Paula L Bockenstedt, John A Heit, Andra H James, Roshni Kulkarni, Marilyn J Manco-Johnson, Stephan Moll, Thomas L Ortel, Claire S Philipp, Ambarina S Faiz, Michele G Beckman, Althea Grant, Paula L Bockenstedt, John A Heit, Andra H James, Roshni Kulkarni, Marilyn J Manco-Johnson, Stephan Moll, Thomas L Ortel

Abstract

Introduction: Black women have an increased risk of adverse pregnancy outcomes and the characteristics of thrombotic risk factors in this population are unknown. The objective of this study was to examine the racial differences in thrombotic risk factors among women with adverse pregnancy outcomes.

Methods: Uniform data were collected in women with adverse pregnancy outcomes (pregnancy losses, intrauterine growth restriction (IUGR), prematurity, placental abruption and preeclampsia) referred to Thrombosis Network Centers funded by the Centers for Disease Control and Prevention (CDC).

Results: Among 343 white and 66 black women seen for adverse pregnancy outcomes, protein S and antithrombin deficiencies were more common in black women. The prevalence of diagnosed thrombophilia was higher among whites compared to blacks largely due to Factor V Leiden mutation. The prevalence of a personal history of venous thromboembolism (VTE) did not differ significantly by race. A family history of VTE, thrombophilia, and stroke or myocardial infarction (MI) was higher among whites. Black women had a higher body mass index, and a higher prevalence of hypertension, while the prevalence of sickle cell disease was approximately 27 fold higher compared to the general US black population.

Conclusions: Thrombotic risk factors differ significantly in white and black women with adverse pregnancy outcomes. Such differences highlight the importance of considering race separately when assessing thrombotic risk factors for adverse pregnancy outcomes.

Keywords: Thrombotic risk factors; adverse pregnancy outcomes; racial disparities; thrombophilia.

Conflict of interest statement

Conflict of interest statement

None declared

© 2013.

Source: PubMed

3
订阅